Influenza virus vaccines are biological formulations designed to provide active acquired immunity against seasonal influenza viruses, with trivalent formulations dominating current options and mRNA technology serving as the newest advancement.
Influenza virus vaccines are biological formulations designed to provide active acquired immunity against seasonal influenza viruses, with trivalent formulations dominating current options and mRNA technology serving as the newest advancement.